Delivery Order SPE2DX22D0089-SPE2D825F2D64
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,635.42 on September 8, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price delivery order, which carries an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,528.93 by the Defense Logistics Agency's Medical Supply Chain on August 24, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,490.76 on August 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 19, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,872.20 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed-price delivery order with no set-aside provisions, is scheduled for ultimate completion on August 29, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,791.72 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion on August 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $1,173.52 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This firm fixed-price delivery order, which represents a child award under a larger contract vehicle, carries an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and utilizes...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $72,974.58 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,983.52 by the Defense Logistics Agency's Medical Supply Chain on August 16, 2025, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed price delivery order under a competitive procurement with no set-aside designation. The award is a child contract issued under AmerisourceBergen's significant Indefinite...
- SPE2DX22D0089Indefinite Delivery Contract
- SPE2DX22D0089-SPE2D825F2D64Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $84,660.70 on June 16, 2025, under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside award, with an ultimate completion date of June 17, 2025, represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The company serves as a critical vendor for federal medical procurement, supplying pharmaceutical products and medical supplies to support military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical contract, AmerisourceBergen Drug Corp fulfills a comprehensive range of medical commodities including brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's performance under the Medical Supply Chain demonstrates its capability to meet federal procurement requirements through competitive award processes, with delivery orders typically structured with firm fixed pricing to support global pharmaceutical support operations for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $84.7k | 6/16/25 |